Debt to Capital Ratio: A measurement of a company's financial leverage, calculated as the company's long-term debt divided by its total capital. Calculated as: Total Long-Term Debt / (Total Long-Term Debt + Shareholders Equity)
Estrella Immunopharma, Inc. (ESLA) Debt to Capital Ratio data is not available.
| Income Statement Financials | |
-- |
|
$-2.29M |
|
-- |
|
-- |
|
$2.29M |
|
$-2.29M |
|
-- |
|
$-2.29M |
|
$-2.29M |
|
$-2.29M |
|
$-2.29M |
|
$-2.29M |
|
$-2.29M |
|
$-2.29M |
|
$-2.29M |
|
42.12M |
|
42.12M |
|
$-0.05 |
|
$-0.05 |
|
| Balance Sheet Financials | |
$2.16M |
|
-- |
|
$1.50M |
|
$3.66M |
|
$8.93M |
|
-- |
|
-- |
|
$8.93M |
|
$-5.27M |
|
$-5.27M |
|
$-5.27M |
|
42.67M |
|
| Cash Flow Statement Financials | |
$-6.70M |
|
-- |
|
$7.24M |
|
$1.38M |
|
$1.93M |
|
$0.54M |
|
$0.15M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.24 |
|
-- |
|
-- |
|
|
Debt to Capital Ratio |
-- |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-6.70M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
43.49% |
|
43.49% |
|
-62.67% |
|
43.49% |
|
$-0.12 |
|
$-0.16 |
|
$-0.16 |
|